Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
5
Number of overlapping holdings
17.9%
% of PBE's 28 holdings also in SBIO
5.9%
% of SBIO's 90 holdings also in PBE
Overlap by Weight
Sector Drift (PBE minus SBIO)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PBE |
Weight in SBIO |
Overlap | |
|---|---|---|---|---|
 |
PTC THERAPEUTICS INC | 2.9% | 3.6% | 2.9% |
|
PROTAGONIST THERAPEUTICS, INC. | 4.1% | 2.8% | 2.8% |
|
ACADIA PHARMACEUTICALS INC | 2.4% | 2.3% | 2.3% |
|
BIOCRYST PHARMACEUTICALS INC | 2.7% | 1.5% | 1.5% |
|
XENCOR INC | 2.1% | 0.7% | 0.7% |
Position Highlights (Non-Overlapping Exposures)
PBE Overweight Relative to SBIO
|
NATERA INC | 5.4% |
|
GILEAD SCIENCES INC | 5.3% |
|
AMGEN INC | 5.0% |
|
NEUROCRINE BIOSCIENCES INC | 4.9% |
|
BIOGEN IDEC INC | 4.7% |
|
UNITED THERAPEUTICS CORP | 4.5% |
|
REGENERON PHARMACEUTICALS | 4.4% |
|
ILLUMINA INC | 4.2% |
|
TG THERAPEUTICS INC | 4.0% |
|
CATALYST PHARMACEUTICAL PART | 3.3% |
PBE Underweight Relative to SBIO
|
AXSOME THERAPEUTICS, INC. | -4.4% |
 |
ALKERMES PLC | -4.1% |
|
RHYTHM PHARMACEUTICALS, INC. | -3.8% |
|
AVIDITY BIOSCIENCES INC | -3.1% |
 |
ZAI LAB LTD. UNSPONSORED ADR | -2.9% |
 |
MERUS N.V. | -2.9% |
|
AKERO THERAPEUTICS, INC. | -2.9% |
|
CRINETICS PHARMACEUTICALS INC | -2.7% |
 |
MOONLAKE IMMUNOTHERAPEUTICS CLASS A | -2.4% |
|
AMICUS THERAPEUTICS INC | -2.0% |